Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innovative Cryo Tubes Feature Advantages for High-Throughput Storage

By LabMedica International staff writers
Posted on 24 Feb 2014
A new cryogenic storage solution provides more reliable biobanking of samples while reducing space utilization. More...


Greiner Bio-One (Kremsmuenster, Austria), a technology partner for the diagnostic, pharmaceutical, and biotechnology industries, is expanding its product portfolio to include a solution for high-throughput sample storage in automated storage systems. At Analytica 2014 (April 1-4, Munich, Germany), Greiner Bio-One GmbH (Frickenhausen, Germany), division of Greiner Bio-One, will be presenting this solution for valuable sample storage in biorepositories using the new "Cryo.s" biobanking tubes. Cryo.s tubes feature a 30% reduction in height as compared to standard cryo tubes, allowing for a more optimized utilization of available space in deep freezers and liquid nitrogen tanks. Thus, Cryo.s tubes also contribute to substantial savings on energy consumption and costs for equipment and maintenance.

Made of medical-grade polymer with proven low content of leachables and an optimized screw-cap design with silicon gasket, Cryo.s tubes are ideal for storage over long periods at extremely low temperatures, such as in gas phase over liquid nitrogen. Both features minimize risk of sample contamination or sample loss over time.

The new tubes are available in volumes of 300 µl, 600 µl, and 1,000 µl, and are supplied in automation-friendly cryo racks. Equipped with decapper-friendly screw caps, they can be opened and closed with automated equipment. Furthermore, a unique datamatrix code on the tubes guarantees for machine-assisted, error-proof identification of individual samples, making Cryo.s tubes well suited also for automated processing of large sample quantities.

Related Links:

Greiner Bio-One



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.